Beckman, Orchid Patent Suit Against Sequenom is Dismissed | GenomeWeb

NEW YORK (GenomeWeb News) – A patent infringement suit filed a year ago by Beckman Coulter and Orchid Cellmark against Sequenom has been dismissed, Sequenom disclosed in a filing with US Securities and Exchange Commission today.

Sequenom said that on June 22, the parties filed a stipulation of dismissal with the US District Court for the Southern District of California in which the claims made by Beckman and Orchid were dismissed, as were the counterclaims by Sequenom. The parties agreed to bear their own attorneys' fees and costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.